Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 80196
Gene Symbol: RNF34
RNF34
0.100 Biomarker disease BEFREE In conclusion, our data demonstrate that the HAIN test is an accurate rapid test for detecting both RIF and INH resistance in TB patients. 31814743 2019
Entrez Id: 54509
Gene Symbol: RHOF
RHOF
0.100 Biomarker disease BEFREE In conclusion, our data demonstrate that the HAIN test is an accurate rapid test for detecting both RIF and INH resistance in TB patients. 31814743 2019
Entrez Id: 339487
Gene Symbol: ZBTB8OS
ZBTB8OS
0.010 Biomarker disease BEFREE The anterior only approach using the ARCH system is as effective as the combined anterior and posterior approach and is less traumatic in treating lumbosacral tuberculosis. 31811159 2019
Entrez Id: 50616
Gene Symbol: IL22
IL22
0.100 Biomarker disease BEFREE Our findings suggest that the IL-22 pathway may be a novel target for therapeutic intervention in T2DM patients with active TB disease. 31809521 2019
Entrez Id: 26253
Gene Symbol: CLEC4E
CLEC4E
0.070 Biomarker disease BEFREE We synthesized and evaluated the immunostimulatory capacity of a library aryl trehalose derivatives and evaluated the structure activity relationship of the compounds in terms of the ability of compounds to engage the Mincle receptor, induce production of innate cytokines from human and murine cells, induce a pro-Th17 cytokine profile from primary human peripheral blood mononuclear cells and demonstrated efficacy in generating antibodies in combination with a tuberculosis antigen M72 in a mouse model. 31809053 2020
Entrez Id: 5034
Gene Symbol: P4HB
P4HB
0.100 GeneticVariation disease BEFREE Foreign nationality, non-Chinese ethnicity, and age above 40 years were independently associated with baseline LTBI, whereas having >2 TB exposure episodes and working in internal medicine, medical subspecialties, and psychiatry wards were associated with QFT-GIT conversion. 31806237 2019
Entrez Id: 260431
Gene Symbol: COPD
COPD
0.030 Biomarker disease BEFREE Correction: Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD. 31805169 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.100 Biomarker disease BEFREE We report the case of successfully treated a patient with reactive arthritis induced by active extra-articular tuberculosis with a TNF inhibitor after sufficient antitubercular treatment. 31804308 2019
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.100 AlteredExpression disease BEFREE However, higher serum levels of IL-6 in tuberculosis patients may explain the pulmonary parenchymal damage. 31800922 2019
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.100 Biomarker disease BEFREE The median interval between starting anti-TNF-α therapy and TB diagnosis was 13.1 (IQR:7.1-20.3) months. 31796965 2019
Entrez Id: 692227
Gene Symbol: SNORD104
SNORD104
0.010 AlteredExpression disease BEFREE SNORD104 expression decreased during <i>M. tuberculosis</i> infection of primary human peripheral blood mononuclear cells (PBMC) and M2-like (<i>P</i> = 0.03) but not M1-like (<i>P</i> = 0.31) macrophages, suggesting that its downregulation in peripheral blood in TB is biologically relevant. 31796535 2019
Entrez Id: 5515
Gene Symbol: PPP2CA
PPP2CA
0.010 AlteredExpression disease BEFREE It has been reported previously that the catalytic subunit of protein phosphatase 2A (PP2Ac) is crucial for regulating AMP-activated protein kinase (AMPK)-mediated autophagic signaling pathways, yet its role in tuberculosis is still unclear.Here, we demonstrated that <i>M. bovis</i> infection increased PP2Ac expression in murine macrophages, while nilotinib a tyrosine kinase inhibitor (TKI) significantly suppressed PP2Ac expression. 31795474 2019
Entrez Id: 1666
Gene Symbol: DECR1
DECR1
0.030 Biomarker disease BEFREE A Novel Genetic Variation in <i>NCF2</i>, the Core Component of NADPH Oxidase, Contributes to the Susceptibility of Tuberculosis in Western Chinese Han Population. 31794672 2020
Entrez Id: 57862
Gene Symbol: ZNF410
ZNF410
0.020 GeneticVariation disease BEFREE We found that the rs10911362 variants were associated with a decreased TB risk in this population (odds ratio [OR<sub>G</sub>] = 0.83 [0.72-0.95], OR<sub>add</sub> = 0.83 [0.72-0.95], OR<sub>dom</sub> = 0.78 [0.66-0.93], <i>p</i> < 0.05). rs10911362 might fall in a transcriptional factor binding site associated with ZNF410 and may be the expression quantitative trait loci (eQTL) for the SMG7 gene according to the Ensembl data. 31794672 2020
Entrez Id: 9887
Gene Symbol: SMG7
SMG7
0.010 GeneticVariation disease BEFREE We found that the rs10911362 variants were associated with a decreased TB risk in this population (odds ratio [OR<sub>G</sub>] = 0.83 [0.72-0.95], OR<sub>add</sub> = 0.83 [0.72-0.95], OR<sub>dom</sub> = 0.78 [0.66-0.93], <i>p</i> < 0.05). rs10911362 might fall in a transcriptional factor binding site associated with ZNF410 and may be the expression quantitative trait loci (eQTL) for the SMG7 gene according to the Ensembl data. 31794672 2020
Entrez Id: 50506
Gene Symbol: DUOX2
DUOX2
0.010 GeneticVariation disease BEFREE In our study, we aimed at investigating the association of polymorphisms in neutrophil cytosolic factor 2 (<i>NCF2</i>) gene, the core component of NADPHO, with susceptibility of TB in the Western Chinese Han population. 31794672 2020
Entrez Id: 4688
Gene Symbol: NCF2
NCF2
0.010 GeneticVariation disease BEFREE In our study, we aimed at investigating the association of polymorphisms in neutrophil cytosolic factor 2 (<i>NCF2</i>) gene, the core component of NADPHO, with susceptibility of TB in the Western Chinese Han population. 31794672 2020
Entrez Id: 53905
Gene Symbol: DUOX1
DUOX1
0.010 GeneticVariation disease BEFREE In our study, we aimed at investigating the association of polymorphisms in neutrophil cytosolic factor 2 (<i>NCF2</i>) gene, the core component of NADPHO, with susceptibility of TB in the Western Chinese Han population. 31794672 2020
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.100 GeneticVariation disease BEFREE To estimate the incidence of tuberculosis in patients receiving TNF inhibitors therapy for rheumatic diseases. 31790428 2019
Entrez Id: 10599
Gene Symbol: SLCO1B1
SLCO1B1
0.040 GeneticVariation disease BEFREE The role of African predominant SLCO1B1 variant alleles on rifampicin pharmacokinetics and the subsequent effect on the occurrence of Mycobacterium tuberculosis-rifampicin sensitivity needs to be defined. 31789383 2020
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.100 AlteredExpression disease BEFREE BCG-infection also induced the expression of TNF receptor 2 on CD3<sup>+</sup> myeloid cells, which increased after BCG-infection, suggesting that the tmTNF/TNFRs axis plays an important role in the presence or function of these cells in tuberculosis. 31787969 2019
Entrez Id: 7249
Gene Symbol: TSC2
TSC2
0.100 Biomarker disease BEFREE The WHO-endorsed immunodiagnostic Alere Determine Lipoarabinomannan Ag-test (LAM-test) detects Mycobacterium tuberculosis complex LAM in urine, and its use is recommended for TB diagnosis among HIV co-infected individuals with low CD4 T-cell counts. 31784649 2019
Entrez Id: 7248
Gene Symbol: TSC1
TSC1
0.100 Biomarker disease BEFREE The WHO-endorsed immunodiagnostic Alere Determine Lipoarabinomannan Ag-test (LAM-test) detects Mycobacterium tuberculosis complex LAM in urine, and its use is recommended for TB diagnosis among HIV co-infected individuals with low CD4 T-cell counts. 31784649 2019
Entrez Id: 2520
Gene Symbol: GAST
GAST
0.020 Biomarker disease BEFREE Most of the compounds showed significant activity against Mycobacterium tuberculosis H37Rv strain with minimum inhibitory concentration (MIC) values in 20-40 μM range in GAST/Fe medium when compared with triclosan (43 μM) in the first week of assay, and after additional incubation, seven compounds, that is, 2a, 2c, 2g, 2h, 2i, 2j, and 2m, exhibited MIC values at the concentration of 20-40 μM. 31782209 2019
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.100 AlteredExpression disease BEFREE After 24 hr ESAT-6 1 <i>μ</i>g/ml stimulation, the percentage of IL-1b-expressed hMDM was borderline lower in the active TB patients (<i>n</i> = 9) than in the LTBI cases (<i>n</i> = 10) (14.0 ± 11.2% vs. 31.6 ± 22.5%, <i>P</i> = 0.065). 31781307 2019